Dr. Kapoor on Advice for Oncologists Treating Patients With Myeloma

Video

In Partnership With:

Prashant Kapoor, MD, hematologic oncologist, Mayo Clinic, shares advice for community oncologists who are treating patients with multiple myeloma.

Prashant Kapoor, MD, hematologic oncologist, Mayo Clinic, shares advice for community oncologists who are treating patients with multiple myeloma.

Oncologists should be using the revised International Myeloma Working Group criteria when treating their newly diagnosed patients with multiple myeloma, Kapoor explains. He also emphasizes the identification of the new response categories, as minimal residual disease-negative states can be achieved with the use of newer therapies.

Community physicians should remember to refer patients for clinical trials but also for transplant earlier in their disease course, even if patients prefer to not undergo this treatment upfront. It is important to collect stem cells for a patient who is eligible for autologous stem cell transplantation, Kapoor adds.

Related Videos
Ricardo D. Parrondo, MD, hematologist/oncologist, Mayo Clinic
Ilyas Sahin, MD
Raj Singh, MD
Jaime R. Merchán, MD, professor, co-leader, Translational and Clinical Oncology Research Program, director, Phase 1 Clinical Trials Program, Department of Medicine, Division of Medical Oncology, the University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center
Saad J. Kenderian, MB, CHB
Tycel Phillips, MD
Minesh Mehta, MD
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,